共 21 条
[1]
Fibrosis Severity as a Determinant of Cause-specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease.[J].Eduardo Vilar-Gomez;Luis Calzadilla-Bertot;Vincent Wai-Sun Wong;Marlen Castellanos;Rocio Aller-de la Fuente;Mayada Metwally;Mohammed Eslam;Licet Gonzalez-Fabian;María Alvarez-Qui?ones Sanz;Antonio Felix Conde-Martin;Bastiaan De Boer;Duncan McLeod;Anthony Wing Hung Chan;Naga Chalasani;Jacob George;Leon A. Adams;Manuel Romero-Gomez.Gastroenterology.2018,
[2]
Noninvasive Prediction of Esophageal Varices by Stiffness and Platelet in Nonalcoholic Fatty Liver Disease Cirrhosis.[J].Salvatore Petta;Giada Sebastiani;Elisabetta Bugianesi;Mauro Viganò;Vincent Wai-Sun Wong;Annalisa Berzigotti;Anna Ludovica Fracanzani;Quentin M. Anstee;Fabio Marra;Marco Barbara;Vincenza Calvaruso;Calogero Cammà;Vito Di Marco;Antonio Craxì;Victor de Ledinghen.Journal of Hepatology.2018,
[5]
SAT-490 - Serum Pro-C3 combined with clinical parameters is superior to established serological fibrosis tests at identifying patients with advanced fibrosis among patients with non-alcoholic fatty liver disease.[J].S.J. Daniels;M.J. Nielsen;A. Krag;M. Eslam;M.A. Karsdal;D.J. Leeming;J. George.Journal of Hepatology.2017, 1

